Company Profile
Updated: 09-SEP-09Addex Pharma S.A.
International Private company
Chemin Des Aulx 12, Plan-Les-Ouates, 1228, Switzerland
()228841555, 228841556 fax,
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Commercial Physical Research
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain.
Business Wire; 11/12/2009; 1674 words; ...pain patients in the U.S. and EU and up to 30 percent...130 countries. Abbott's news releases and other information...available on the company's Web site at www.abbott...portfolio companies include Addex Pharma, Cellzome, Funxional Therapeutics...
Addex Brings In CHF40M For CNS Product Studies.
BIOWORLD Today; 11/3/2009; 1439 words; ...International Correspondent Addex Pharmaceuticals SA raised...indications. Two big pharma-backed venture capital...Geneva-based company's roster of investors...supported the round. Addex, which was established...commercialization. "We believe it's the only way to maximize...
ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing.
PR Newswire; 8/24/2009; 1018 words; ...Ablynx (Belgium), Acacia Pharma (UK), Agendia (Netherlands...Netherlands), Ascendis Pharma (Denmark), Chroma Therapeutics...Switzerland), Santaris Pharma (Denmark) and Symphogen...a full list of Gilde's portfolio companies please...Previous investments include Addex Pharmaceuticals, ...
ProFibrix Raises US $11 Million (EUR 8 Million) in Series B Financing.
PR Newswire Europe; 8/24/2009; 1030 words; ...Ablynx (Belgium), Acacia Pharma (UK), Agendia (Netherlands...Netherlands), Ascendis Pharma (Denmark), Chroma Therapeutics...Switzerland), Santaris Pharma (Denmark) and Symphogen...a full list of Gilde's portfolio companies please...Previous investments include Addex Pharmaceuticals, ...
Other News To Note.
BIOWORLD Today; 7/13/2009; 1057 words; ...animal model of Parkinson's disease. The collaboration...mGluR4 for Parkinson's disease and other undisclosed indications. Addex received $250,000 after...undergo angioplasty. Lilly's partner in the drug is...next few months. Sciele Pharma Inc., of Atlanta, and...
Recent News Articles
- Swiss allosteric modulation company Addex Pharmaceuticals has signed a second collaboration within a month with US pharma major Merck & Co, in this case, for the development of a new schizophrenia drug ADX63365, which is a positive allosteric modulator (PAM) that targets the metabotropic glutamate receptor 5 (mGluR5), in a deal worth up to $700m.(Research briefs)(Brief article)
Chemistry and Industry - February 25, 2008 - Addex Pharma plans IPO on SWX.(SWX Swiss Exchange)(initial public offering)(Brief article)
Pharma Marketletter - April 30, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning